1. Home
  2. Labeler Index
  3. Sandoz Inc
  4. 0781-3529
  5. NDC Package Code: 0781-3529-10 Cyclophosphamide

NDC Package 0781-3529-10 Cyclophosphamide

Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0781-3529-10
Package Description:
1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE (0781-3529-70)
Product Code:
0781-3529
Proprietary Name:
Cyclophosphamide
Non-Proprietary Name:
Cyclophosphamide
Substance Name:
Cyclophosphamide
Usage Information:
Cyclophosphamide is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked.
11-Digit NDC Billing Format:
00781352910
NDC to RxNorm Crosswalk:
  • RxCUI: 2679073 - cycloPHOSphamide 100 MG/ML Injectable Solution
  • RxCUI: 2679073 - cyclophosphamide 100 MG/ML Injectable Solution
  • RxCUI: 2679073 - cyclophosphamide (as cyclophosphamide monohydrate) 100 MG/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sandoz Inc
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • CYCLOPHOSPHAMIDE 1000 mg/10mL
    • Sample Package:
    No
    FDA Application Number:
    NDA217150
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    04-08-2024
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0781-3529-10?

    The NDC Packaged Code 0781-3529-10 is assigned to a package of 1 vial, multi-dose in 1 carton / 10 ml in 1 vial, multi-dose (0781-3529-70) of Cyclophosphamide, a human prescription drug labeled by Sandoz Inc. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 0781-3529 included in the NDC Directory?

    Yes, Cyclophosphamide with product code 0781-3529 is active and included in the NDC Directory. The product was first marketed by Sandoz Inc on April 08, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0781-3529-10?

    The 11-digit format is 00781352910. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20781-3529-105-4-200781-3529-10